|
2020 Journal Article Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin (Intensive Care Medicine, (2020), 46, 4, (766-770), 10.1007/s00134-019-05890-w)Rouby, J. J., Sole-Lleonart, C., Rello, J., Monsel, Antoine, Constantin, Jean-Michel, Bouglé, Adrien, Blot, Stijn, Poulakou, Garyphalia, Pontikis, Konstantinos, Kyriakoudi, Anna, Koutsoukou, Antonia, Dimopoulos, George, Routsi, Christina, Arvaniti, Kostoula, Pereira, Jose Manuel, Felton, Timothy, Dhanani, Jayesh, Roberts, Jason, Bassetti, Matteo, Welte, Tobias, Dugernier, Jonathan, Laterre, Pierre-François, Ehrmann, Stephan, Boisson, Matthieu, Mimoz, Olivier, Leone, Marc, Palmer, Lucy B., Pugin, Jérôme, Qu, Jie-ming ... Liao, Xuelian (2020). Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin (Intensive Care Medicine, (2020), 46, 4, (766-770), 10.1007/s00134-019-05890-w). Intensive Care Medicine, 46 (4), 766-770. doi: 10.1007/s00134-020-05986-8 |
|
2020 Journal Article The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy StudyRoberts, Jason A., Joynt, Gavin M., Lee, Anna, Choi, Gordon, Bellomo, Rinaldo, Kanji, Salmaan, Mudaliar, M Yugan, Peake, Sandra L., Stephens, Dianne, Taccone, Fabio Silvio, Ulldemolins, Marta, Valkonen, Miia Maaria, Agbeve, Julius, Baptista, João P., Bekos, Vasileios, Boidin, Clement, Brinkmann, Alexander, Buizen, Luke, Castro, Pedro, Cole, C. Louise, Creteur, Jacques, De Waele, Jan J., Deans, Renae, Eastwood, Glenn M., Escobar, Leslie, Gomersall, Charles, Gresham, Rebecca, Jamal, Janattul Ain, Kluge, Stefan ... Young, Helen (2020). The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study. Clinical Infectious Diseases, 72 (8), 1369-1378. doi: 10.1093/cid/ciaa224 |
|
2020 Journal Article Development of Population and Bayesian Models for Applied Use in Patients Receiving CefepimeLiu, Jiajun, Neely, Michael, Lipman, Jeffrey, Sime, Fekade, Roberts, Jason A., Kiel, Patrick J., Avedissian, Sean N., Rhodes, Nathaniel J. and Scheetz, Marc H. (2020). Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime. Clinical Pharmacokinetics, 59 (8), 1027-1036. doi: 10.1007/s40262-020-00873-3 |
|
2020 Journal Article Amoxicillin-clavulanate dosing in the intensive care unit: the additive effect of renal replacement therapy in a patient with normal kidney functionLonsdale, Dagan Osborne, Lipman, Jeffrey, Livermore, Amelia, McWhinney, Brett, Ungerer, Jacobus P.J. and Roberts, Jason A. (2020). Amoxicillin-clavulanate dosing in the intensive care unit: the additive effect of renal replacement therapy in a patient with normal kidney function. Chemotherapy, 64 (4), 1-4. doi: 10.1159/000505057 |
|
2020 Journal Article Evaluation of target attainment of oral posaconazole suspension in immunocompromised childrenLai, Tony, Alffenaar, Jan-Willem, Kesson, Alison, Bandodkar, Sushil and Roberts, Jason A. (2020). Evaluation of target attainment of oral posaconazole suspension in immunocompromised children. Journal of Antimicrobial Chemotherapy, 75 (3), 726-729. doi: 10.1093/jac/dkz481 |
|
2020 Journal Article β-lactam antibiotic versus combined β-lactam antibiotic and single-daily dosing regimens of aminoglycosides for the treatment of serious infections: a meta-analysisHeffernan, Aaron James, Sime, Fekade Bruck, Sun, Jing, Lipman, Jeffrey, Kumar, Anand, Andrews, Katherine, Ellwood, David, Grimwood, Keith and Roberts, Jason (2020). β-lactam antibiotic versus combined β-lactam antibiotic and single-daily dosing regimens of aminoglycosides for the treatment of serious infections: a meta-analysis. International Journal of Antimicrobial Agents, 55 (3) 105839, 105839. doi: 10.1016/j.ijantimicag.2019.10.020 |
|
2020 Journal Article Finding the relevance of antimicrobial stewardship for cystic fibrosisCogen, Jonathan D., Kahl, Barbara C., Maples, Holly, McColley, Susanna A., Roberts, Jason A., Winthrop, Kevin L., Morris, Andrew M., Holmes, Alison, Flume, Patrick A., VanDevanter, Donald R., Waters, Valerie, Muhlebach, Marianne S., Elborn, J. Stuart, Saiman, Lisa and Bell, Scott C. (2020). Finding the relevance of antimicrobial stewardship for cystic fibrosis. Journal of Cystic Fibrosis, 19 (4), 511-520. doi: 10.1016/j.jcf.2020.02.012 |
|
2020 Journal Article The challenge of quantifying and managing pharmacokinetic variability of beta-lactams in the critically illCrass, Ryan L., Williams, Paul and Roberts, Jason A. (2020). The challenge of quantifying and managing pharmacokinetic variability of beta-lactams in the critically ill. Anaesthesia Critical Care and Pain Medicine, 39 (1), 27-29. doi: 10.1016/j.accpm.2019.12.008 |
|
2020 Journal Article β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically illWong, Gloria, Taccone, Fabio, Villois, Paola, Scheetz, Marc H., Rhodes, Nathaniel J., Briscoe, Scott, McWhinney, Brett, Nunez-Nunez, Maria, Ungerer, Jacobus, Lipman, Jeffrey and Roberts, Jason A. (2020). β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill. Journal of Antimicrobial Chemotherapy, 75 (2), 429-433. doi: 10.1093/jac/dkz437 |
|
2020 Journal Article Oral fosfomycin efficacy with variable urinary exposures following single and multiple doses against Enterobacterales: the importance of heteroresistance on growth outcomeAbbott, Iain J., van Gorp, Elke, Wijma, Rixt A., Meletiadis, Joseph, Roberts, Jason A., Mouton, Johan W. and Peleg, Anton Y. (2020). Oral fosfomycin efficacy with variable urinary exposures following single and multiple doses against Enterobacterales: the importance of heteroresistance on growth outcome. Antimicrobial Agents and Chemotherapy, 64 (3) e01982-19. doi: 10.1128/aac.01982-19 |
|
2020 Journal Article Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populationsXie, Jiao, Roberts, Jason A., Lipman, Jeffrey, Cai, Yan, Wang, Haitao, Zhao, Nuannuan, Xu, Xiaona, Yang, Shan, Li, Youjia and Zhang, Kanghuai (2020). Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populations. International Journal of Antimicrobial Agents, 55 (6) 105943, 105943. doi: 10.1016/j.ijantimicag.2020.105943 |
|
2020 Journal Article The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)Donnellan, Sine, Wright, Daniel F. B., Roberts, Jason A., Duffull, Stephen B., Schollum, John B. W., Putt, Tracey L., Wallis, Steven C. and Walker, Robert J. (2020). The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF). European Journal of Clinical Pharmacology, 76 (2), 239-247. doi: 10.1007/s00228-019-02792-0 |
|
2020 Journal Article Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patientsYadav, Rajbharan, Bergen, Phillip J., Rogers, Kate E., Kirkpatrick, Carl M. J., Wallis, Steven C., Huang, Yuling, Bulitta, Jürgen B., Paterson, David L., Lipman, Jeffrey, Nation, Roger L., Roberts, Jason A. and Landersdorfer, Cornelia B. (2020). Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patients. Antimicrobial Agents and Chemotherapy, 64 (1) e01679-19. doi: 10.1128/aac.01679-19 |
|
2020 Journal Article Linguistic and cultural adaptation to the Portuguese language of antimicrobial dose adjustment softwareSilva, Samuel Dutra da, Alves, Geisa Cristina da Silva, Chequer, Farah Maria Drumond, Farkas, Andras, Daróczi, Gergely, Roberts, Jason A. and Sanches, Cristina (2020). Linguistic and cultural adaptation to the Portuguese language of antimicrobial dose adjustment software. Einstein (São Paulo), 18, 1-8. doi: 10.31744/einstein_journal/2020ao5023 |
|
2020 Journal Article A population pharmacokinetic model-guided evaluation of ceftolozane/tazobactam dosing in critically ill patients undergoing continuous venovenous hemodiafiltrationSime, Fekade B., Lassig-Smith, Melissa, Starr, Therese, Stuart, Janine, Pandey, Saurabh, Parker, Suzanne L., Wallis, Steven C., Lipman, Jeffrey and Roberts, Jason A. (2020). A population pharmacokinetic model-guided evaluation of ceftolozane/tazobactam dosing in critically ill patients undergoing continuous venovenous hemodiafiltration. Antimicrobial Agents and Chemotherapy, 64 (1) e01655. doi: 10.1128/aac.01655-19 |
|
2020 Journal Article Software for dose adjustment of antimicrobials. Implications for plasma concentrations and pratical limitationsAlves, Geisa Cristina da Silva, Silva, Samuel Dutra da, Chequer, Farah Maria Drumond, Castro, Whocely Victor de, Baldoni, André Oliveira, Farkas, Andras, Daróczi, Gergely, Roberts, Jason Alexander and Sanches, Cristina (2020). Software for dose adjustment of antimicrobials. Implications for plasma concentrations and pratical limitations. Einstein, 18, 1-2. doi: 10.31744/einstein_journal/2020ce5858 |
|
2019 Journal Article Ceftolozane–tazobactam in an elastomeric infusion device for ambulatory care: an in vitro stability studyRaby, Edward, Naicker, Saiyuri, Sime, Fekade Bruck, Manning, Laurens, Wallis, Steven C., Pandey, Saurabh and Roberts, Jason A. (2019). Ceftolozane–tazobactam in an elastomeric infusion device for ambulatory care: an in vitro stability study. European Journal of Hospital Pharmacy, 27 (e1) e19002093, e84-e86. doi: 10.1136/ejhpharm-2019-002093 |
|
2019 Journal Article Saturable elimination of piperacillin in critically ill patients: implications for continuous infusionDhaese, S.A.M., Colin, P., Willems, H., Heffernan, A., Gadeyne, B., Van Vooren, S., Depuydt, P., Hoste, E., Stove, V., Verstraete, A.G., Lipman, J., Roberts, J.A. and De Waele, J.J. (2019). Saturable elimination of piperacillin in critically ill patients: implications for continuous infusion. International Journal of Antimicrobial Agents, 54 (6), 741-749. doi: 10.1016/j.ijantimicag.2019.08.024 |
|
2019 Journal Article Pharmacokinetics and pharmacodynamics of anti-infective agents during continuous veno-venous hemofiltration in critically ill patients: lessons learned from an ancillary study of the IVOIRE trialBreilh, Dominique, Honore, Patrick M., De Bels, David, Roberts, Jason A., Gordien, Jean Baptiste, Fleureau, Catherine, Dewitte, Antoine, Coquin, Julien, Roze, Hadrien, Perez, Paul, Attou, Rachid, Redant, Sebastien, Kugener, Luc, Saux, Marie-Claude, Spapen, Herbert D., Ouattare, Alexandre and Joannes-Boyau, Olivier (2019). Pharmacokinetics and pharmacodynamics of anti-infective agents during continuous veno-venous hemofiltration in critically ill patients: lessons learned from an ancillary study of the IVOIRE trial. Journal of Translational Internal Medicine, 7 (4), 155-169. doi: 10.2478/jtim-2019-0031 |
|
2019 Journal Article Update in antibiotic therapy in intensive care unit: report from the 2019 Nîmes International SymposiumLeone, Marc, Roberts, Jason A., Bassetti, Matteo, Bouglé, Adrien, Lavigne, Jean-Philippe, Legrand, Matthieu, Neely, Michael, Paiva, José-Artur, Payen, Didier, Rello, Jordi, Roger, Claire, Sjövall, Fredrik and Jung, Boris (2019). Update in antibiotic therapy in intensive care unit: report from the 2019 Nîmes International Symposium. Anaesthesia Critical Care and Pain Medicine, 38 (6), 647-656. doi: 10.1016/j.accpm.2019.09.009 |
